Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa.
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa.
复制标题
DOI:
10.1038/s41467-021-23267-w
复制
发表时间:
2021-06-11
影响因子:
16.6
通讯作者:
Jambo KC
中科院分区:
文献类型:
--
作者:
Morton B;Barnes KG;Anscombe C;Jere K;Matambo P;Mandolo J;Kamng'ona R;Brown C;Nyirenda J;Phiri T;Banda NP;Van Der Veer C;Mndolo KS;Mponda K;Rylance J;Phiri C;Mallewa J;Nyirenda M;Katha G;Kambiya P;Jafali J;Mwandumba HC;Gordon SB;Blantyre COVID-19 Consortium;Cornick J;Jambo KC
Although the COVID-19 pandemic has left no country untouched there has been limited research to understand clinical and immunological responses in African populations. Here we characterise patients hospitalised with suspected (PCR-negative/IgG-positive) or confirmed (PCR-positive) COVID-19, and healthy community controls (PCR-negative/IgG-negative). PCR-positive COVID-19 participants were more likely to receive dexamethasone and a beta-lactam antibiotic, and survive to hospital discharge than PCR-negative/IgG-positive and PCR-negative/IgG-negative participants. PCR-negative/IgG-positive participants exhibited a nasal and systemic cytokine signature analogous to PCR-positive COVID-19 participants, predominated by chemokines and neutrophils and distinct from PCR-negative/IgG-negative participants. PCR-negative/IgG-positive participants had increased propensity for Staphylococcus aureus and Streptococcus pneumoniae colonisation. PCR-negative/IgG-positive individuals with high COVID-19 clinical suspicion had inflammatory profiles analogous to PCR-confirmed disease and potentially represent a target population for COVID-19 treatment strategies. Clinical management of COVID-19 in resource-poor settings has distinct challenges and detailed patient characterisation is needed. Here, the authors describe the clinical and immunological profiles of patients at a hospital in Malawi with confirmed and suspected COVID-19.
登录
查看更多内容
影响因子:
64.5
作者:
Hou, Yixuan J.;Okuda, Kenichi;Baric, Ralph S.
通讯作者:
Baric, Ralph S.
DOI:
10.1093/cid/ciaa1605
发表时间:
2021-10-05
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Geretti AM;Stockdale AJ;Kelly SH;Cevik M;Collins S;Waters L;Villa G;Docherty A;Harrison EM;Turtle L;Openshaw PJM;Baillie JK;Sabin CA;Semple MG
通讯作者:
Semple MG
影响因子:
7.7
作者:
Zamorano Cuervo N;Grandvaux N
通讯作者:
Grandvaux N
DOI:
10.1016/j.cmi.2020.07.041
发表时间:
2021-01
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
作者:
Garcia-Vidal C;Sanjuan G;Moreno-García E;Puerta-Alcalde P;Garcia-Pouton N;Chumbita M;Fernandez-Pittol M;Pitart C;Inciarte A;Bodro M;Morata L;Ambrosioni J;Grafia I;Meira F;Macaya I;Cardozo C;Casals C;Tellez A;Castro P;Marco F;García F;Mensa J;Martínez JA;Soriano A;COVID-19 Researchers Group
通讯作者:
COVID-19 Researchers Group
影响因子:
11.8
作者:
Amin-Chowdhury, Zahin;Aiano, Felicity;Ladhani, Shamez N.
通讯作者:
Ladhani, Shamez N.